Journal Article

Adjusting for Screening History in Epidemiologic Studies of Cancer: Why, When, and How to Do It

Noel S. Weiss

in American Journal of Epidemiology

Published on behalf of Johns Hopkins Bloomberg School of Public Health

Volume 157, issue 11, pages 957-961
Published in print June 2003 | ISSN: 0002-9262
Published online June 2003 | e-ISSN: 1476-6256 | DOI: http://dx.doi.org/10.1093/aje/kwg062
Adjusting for Screening History in Epidemiologic Studies of Cancer: Why, When, and How to Do It

More Like This

Show all results sharing this subject:

  • Public Health and Epidemiology

GO

Show Summary Details

Preview

In epidemiologic studies of cancer, differences between exposed and nonexposed persons with regard to a history of cancer screening during the time the malignancy (or an antecedent lesion) typically is present prior to diagnosis can be a source of confounding if one of the following conditions is present: 1) the screening modality identifies premalignant changes whose treatment has the potential to prevent the cancer from developing; or 2) the number of cases included in the study would have been smaller but for the presence of screening. These situations occur commonly, arguing that consideration be given to screening history in the design (with attention to distinguishing true screening tests from those administered to persons with signs or symptoms of cancer) and analysis of epidemiologic studies of those cancers for which screening modalities are in use in the study population.

Keywords: confounding factors (epidemiology); effect modifiers (epidemiology); neoplasms; Abbreviation: NSAID, nonsteroidal antiinflammatory drug.

Journal Article.  3446 words. 

Subjects: Public Health and Epidemiology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.